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                                                           ABSTRACT 
 
AIM : 
                  To study the clinical profile of erythrasma and to compare the effectiveness of 
2% topical clotrimazole cream  vs  2% topical fusidic acid cream in its treatment. 
MATERIAL AND METHODS: 
                  A randomnised  prospective, open labeled  clinical study and a comparative  
 
study of 1 year (Jan 2014-Jan 2015) duration was conducted in 50 patients who were  
 
attending the dermatology  outpatient department of Chengalpattu Medical College 
 
satisfying the inclusion and exclusion criteria after obtaining ethical clearance. 
METHODOLOGY: 
                  The study subjects were first clinically evaluated based on age, sex, 
morphology, association with other corynebacterial infections, other dermatological 
lesions and then blood sugar, thyroid levels done. Specific investigations like gram stain 
,Wood’s lamp ,skin biopsy and culture being done. Then 25 patients  randomly allocated 
into two groups. Group A patients were treated with 2% clotrimazole cream and group B 
were treated with 2% fusidic acid cream applied twice daily.  The patients were followed 
up for 2 weeks. The schedule of patient visit is as follows Visit 1 for initial or baseline 
assessment and follow-up at  7
th
  & 14
th
 day. 
 
 
STATISTICAL ANALYSIS: 
                   The data collected were analyzed using Student t test (two tailed,independent) 
to find the significance of study parameters on continuous scale between two groups. 
Chi-square/ Fisher Exact test was used to find the significance of study parameters on 
categorical scale between two or more groups. 
RESULTS : 
                   Erythrasma was found to be common in 58 % female patients and 50% were 
in middle age group. Morphologically reddish brown lesions  were  found in 88 % 
patients with involvement of groin mostly . 10 cases  were associated with keratolysis 
punctata  and 8 cases with trichomycosis axillaris . Diabetes mellitus, hypothyroidism 
and obesity associated. 2% fusidic acid cream was found to be more effective than  2% 
clotrimazole cream in reduction of colour intensity, demarcation .scaling and  Wood’s 
lamp reflection score. Side effects were not seen in both groups. 
CONCLUSIONS: 
                    Erythrasma was common in middle aged females with reddish brown lesions 
in groin. It was found to be associated with keratolysis punctata, trichomycosis axillaris, 
acanthosis nigricans,acrochordons and systemic diseases like diabetes mellitus , 
hypothyroidism.  2% fusidic acid cream was found to be effective bactericidal than 2% 
clotrimazole cream in erythrasma. 
KEY WORDS: 
                    Erythrasma , 2% clotrimazole cream, 2% fusidic acid cream , efficacy, 
keratolysis punctata, trichomycosis axillaris, diabetes mellitus ,obesity , Wood’s lamp 
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INTRODUCTION 
The normal human skin surface and its follicles is colonized by huge 
numbers of bacteria that live harmlessly as commensals .  At times the overgrowth 
of some of these resident organisms may cause minor disease of skin or its 
appendages. If the immune status of the subject is impaired  or the skin is damaged, 
bacteria usually regarded as nonpathogenic on body surface will assume the role of 
opportunist pathogens. 
Erythrasma is a chronic  superficial bacterial infection of the skin widely 
prevalent all over the world. The causative agent is a gram positive aerobic  
diphtheroid called Corynebacterium minutissimum. Studies carried out by scientists 
regarding its microbiology, pathogenicity, biochemical characters and treatment  
has expanded our knowledge about the condition. These organisms normally 
contribute to cutaneous ecosystem. But when local or systemic devitalizing factors 
are favourable , they behave as pathogens. 
Recently various studies has been conducted for therapeutic trials in 
erythrasma using topical imidazole group of antifungals or fusidic acid and oral 
macrolides . 
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REVIEW OF LITERATURE 
HISTORICAL ASPECTS 
A German scientist Burchardt in 1859,  was the first to describe the disease 
and suggested that the delicate filaments and granules found in the scales were of 
fungal origin and were the cause of the disease [1]. 
The term ‘erythrasma’ was coined in 1862 by Von Baren Sprung, 
Burchardt’s teacher. He named the causative organism as Microsporum 
minutissimum. 
Most of subsequent workers like Koebner 1884; Balzer and Dubrevilh 1883; 
Unna 1896  had no doubt that erythrasma was a separate entity. Some workers 
including  Weyl (1884) considered that various transitional forms existed between 
erythrasma and pityriasis versicolour. Gougerot (1936) was  the one to recognise 
disseminated and subacute forms of erythrasma and pointed out that the condition 
can be complicated by eczematization or can be associated with bacterial or fungal 
infections. Koebner in 1884 was the first person to reproduce disease  by applying 
the scales infected with erythrasma to the skin of one of his pupils [2]. 
The numerous names appeared in the literature for the causative organism of 
erythrasma includes Microsporum minutissimum, Nocardia minutissimum and 
Sporotrichum minutissimum [3]. 
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Poehlmann (1928) considered local factors such as site, humidity, body 
secretions,  individual predisposition, sweating, a delicate integument and systemic 
illness like diabetes mellitus for the causation of erythrasma. 
Robean and Guerra (1936) gave an account of 16 patients with the condition 
involving the toe-webs and few of them had  associated fungal infection. 
Nikolowski and Stable (1949) reported an unusual form of erythrasma 
involving forearms . The generalised form  was reported by Goncalves and 
Mangeon (1960) which is characterised by well defined scaly lamellated plaques in 
the trunks and limbs. 
Lagana (1960) was the first to suggest  the bacterial cause for erythrasma . 
Sarkany, Taplin and Blank (1961) isolated a diphtheroid which they named 
Corynebacterium minutissimum from the lesions of erythrasma and thus gave way 
for  a new outlook on the condition for subsequent scientists to carry out their work 
[4]
. Now various studies are  being carried out relating  erythrasma to obesity, 
diabetes mellitus and its association with other fungal conditions like pityriasis 
versicolour and dermatophytosis. 
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EPIDEMIOLOGY OF ERYTHRASMA 
The incidence of erythrasma is  reported to be around  4.5%. This infection is 
observed all over the world; the widespread form is found more frequently in the 
subtropical and tropical areas. Mild forms of erythrasma of axilla, groins and toe-
webs are relatively common in temperate climates; the less common generalised 
form is predominantly seen in obese subjects particularly in middle aged Negro 
women. 
Incidence is higher in communities like the armed forces and various 
institutions.  In some institutions, the infection appears to be endemic and the 
incidence among the patients remaining relatively constant over a period of years. 
Sarkany, Taplin and Blank in 1962 found that  the incidence is higher in tropical 
climates and generalized type is frequently common[5]. The incidence usually 
increases with age and a case has been  recorded in one year old child which was 
studied by Laube S (2004) [6]. 
Eventhough  both sexes are equally affected by erythrasma, the crural form 
of erythrasma is more common in men. A study  conducted in the year 2008 found 
out that interdigital erythrasma was more common in women [7]. 
Erythrasma is not significantly contagious. Holdiness (2003)   found out that 
factors such as warm climate, poor hygiene, obesity, hyperhidrosis, advanced age 
and diabetes mellitus play a role in the occurrence of the disease [8]. 
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Bowyer A (1971) showed  that erythrasma could be associated with pruritus 
ani[9].  A study reported  that 11%  patients with mental abnormalities had  
involvement of perianal areas. 
The association of erythrasma  with dermatophytosis of groin  was reported 
by Schlappner OL, Rosenblum GA in 1979  [10]. When lesions were seen in groin 
and axillae, it was associated with pityriasis versicolour   [11].  
The incidence and severity of erythrasma is apparently greater amongst   
diabetics . Somerville and Lancaster in 1973 found that carriage of fluorescent 
diphtheroid was greater even in milder forms  of diabetics [12]. It is possible that 
diabetics are as susceptible to erythrasma like candidiasis and this is perhaps related 
to the high levels of  free glucose in the skin as shown in a review article by  
Haroon TS (1974) [13]. Montes LF and Dobson H et al  also studied the association 
of  diabetes mellitus and erythrasma in 1969 [14].  Obesity is a predisposing factor 
for the development of erythrasma was reported by Schein-feld NS (2004). The 
occurence of erythrasma is not affected by use of deodorants [15]. 
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NORMAL CUTANEOUS FLORA AND DIPHTHEROIDS 
For a better understanding of the disease,  it is important to mention a few 
words about the normal flora of skin. 
Skin bacteria are of 2 types transients and residents. Transients  are most 
abundantly present on exposed skin  and   few numbers are seen on clean 
unexposed skin. The resident flora is a relatively stable  both in  composition and 
size. 
Gram positive cocci like Staphylococcus species and Micrococcus species, 
Gram positive rods like the coryneform mainly Corynebacterium spp. and 
Brevibacterium species constitute aerobic resident flora. The only significant gram 
negative  residents are Acinetobacter species which was previously known as Mima 
and Herellea.The coryneform (or diphtheroid) organisms are mostly  Gram positive 
nonsporing  aerobic  pleomorphic rods.  
The coryneform bacteria are difficult to get separated by conventional 
taxonomic methods and chemotaxonomic methods.  The  aerobic coryneforms are 
divided into four corynebacterium species complexes -C.xerosis, C.minutissimum, 
C.bovis and C.hofmani with Brevibacterium  and Propionibacterium spp. making 
up a total of six groups by recently proposed scheme [16]. 
Cutaneous diphtheroids initially were assigned to different groups based on 
their oxygen requirements. The anerobic under the term Propionibacterium acnes 
and aerobic diphtheroids  are classified according to their origin, tyrosine clearance, 
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obligate  lipophilicity and nitrate reduction. P.acnes are mainly associated with 
follicles  over face and upper trunk as they have large pilosebaceous glands [16]. It 
has a role in pathogenesis of acne lesions . 
CORYNEFORM BACTERIA 
They are  human commensals or pathogens 
Aerobic 
Corynebacterium diphtheria                         
Corynebacterium haemolyticum  
C.pyogenes 
C.xerosis 
C.hoffmani 
C.minuttissimum 
Anerobic 
Propionibacterium acnes 
P.granulosum 
P.avidum 
Pathogens which sometimes infect humans 
Listeria monocytogenes 
Erysipelothrix rusiopathiae 
Primarily skin 
Primarily follicular 
Primarily throat 
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In  adult life, aerobic diphtheroids are commonly found in large numbers on 
the skin. Two characteristics features of these aerobic diphtheroids are porphyrin 
production and lipophilia . Sebum is an important source of metabolites for both the 
anerobic and aerobic diphtheroids. All lipid dependent strains hydrolyse palmitate 
which is the most common fatty acid formed in human surface lipids. 
Porphyrin production could be demonstrated by examining under UV light 
which shows typical coral red fluorescence in the cultures grown on suitable media . 
Sarkany, Taplin & Blank detected that  porphyrin production by the diphtheroid 
was responsible for erythrasma in 1961 [17]. This characteristics are more prevalent 
amongst corynebacteria than expected. In addition to C.minutissimum, C.bovis,  
C.xerosis ,  primarily follicular C.ulcerans and  C.renale also show fluorescence. 
C.diphtheriae is known to produce coproporphyrin III under conditions of iron 
deficiency and the red fluorescence of the comedones of face has been shown to be 
due to the production of  protoporphyrin IX and coproporphyrin III by P.acnes. 
In 1973, Somerville used nine simple tests (lipophilia, glucose fermentation, 
nitrate reduction ) to arrange the aerobic cutaneous diphtheroids into 15 groups in 
which  seven were porphyrin producers and eight  were non- porphyrin 
producers[12]. 
Montes and his colleagues demonstrated  an apparent bacteriophage cycle in 
diphtheroids on human skin using an electron microscope. Phages have been 
isolated from various species of corynebacteria other than C.diphtheriae. 
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In most  people the aerobic diphtheroids can be isolated from the skin in 
virtually all parts of the body. They are particularly common in groin, axilla and toe 
webs. 
Age has an important role in determining the occurence of the infection. In 
newborn period,  relatively few organisms are seen and within few hours there is an 
increase in number . Incidence increase in childhood with highest  in young adults. 
It has been suggested that   increase in the amount of sebum secreted on to the skin 
at puberty  favours the survival and growth of these organisms as they are lipolytic 
and some lipophilic. In the axilla the micrococci with diphtheroids contribute to the 
development of axillary odour. 
The role of diphtheroids as normal flora is high. They cause erythrasma , 
keratolysis punctata , trichomycosis axillaris and acne only in few people. 
MICROBIOLOGY OF CORYNEBACTERIUM MINUTISSIMUM 
C.minutissimum which is an aerobic diphtheroid has common morphologic 
features of diphtheroids. On staining with Gram stain, the isolates from the skin 
lesion of  fluorescent scales of erythrasma show rod like organisms, coccoid forms 
and filaments.The filaments measure about 4µ to 10µ by 1µ and are tortuous. The 
longer filaments  have beaded or segmented appearance. The bacillary forms are 
about 1µ-3µ in length and 0.5µ in diameter. Some reveal subterminal granules. 
The shorter  forms are more profuse in the erythrasma lesions of toes, 
however chains of bacilli and filamentous forms are also found [1]. The lesions often 
contain higher proportion of filaments and few  shorter bacillary forms. 
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Under electron microscope [18] ,most of the bacteria will be seen at the level 
of  stratum corneum. They are proliferating over the skin surface between cornified 
cells .They penetrate these cells from the intercellular space, directly from the skin 
surface or  intracellularly within the keratinised cells. 
Most of the organisms within  the skin surface have  homogenous fine 
structures. But  in the stratum corneum pleomorphism is observed. Also  
multiplying organisms are more common on the surface than within the stratum 
corneum. 
The stratum corneum is hyperkeratotic with superficial layers being  widely 
separated and  cell boundaries getting disrupted at the sites of  penetration of 
organisms.  Cytoplasmic areas of keratinocytes show decreased electronic density 
which is  observed  mainly around the intracellular bacteria probably suggesting a 
keratolytic process. 
Electron micrographs of the full stratum corneum thickness showed that the 
bacteria in erythrasma will penetrate as deeply as one-half of the thickness of that 
layers . Bacteriophages can apparently exist within the bacterial cell[19].     
Skin  surface biopsy technique was used by R.Marks and N.D.Ramnarain 
(1972) to study erythrasma patients [3]. The skin surface biopsies were subjected to 
scanning electron microscope studies and enzyme histochemical reactions. Skin 
biopsies from the affected sites when  stained with  Periodic Acid Schiff ( PAS ) 
reagent or Gram stain demonstrated the presence of numerous fusiform 
microorganisms which are arranged in clusters, singly or chains and scattered over 
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various areas .The chains were  usually comprised of  three, four or occasionally 
more bacterial cells. The microorganisms were approximately three to four times 
longer than broader. 
There was noticeable diffuse staining of the sites containing the 
microorganisms which was visible macroscopically with PAS stain. There was not 
any particular accentuation around hair follicles or sweat gland openings. 
Corynebacterium minutissimum possess a wide range of enzyme activities as 
shown by enzyme histochemical methods. Mitochondrial enzyme activities 
especially Nicotinamide Adenine Dinucleotide diaphorase and lactic dehydrogenase  
activities were particularly strong. The reaction products from the tests performed 
were not diffusely distributed within the individual bacterial cells but appeared as 
well defined foci of aggregations within each cell. 
Single rod shaped and oval structures and chains were seen lying  embedded 
in the surface of the individual cornified cells with the scanning electron 
microscope. The surface of the  cells were regularly smooth. The chain of bacterial 
cells would frequently seen to be penetrating the cornified cells.  Several  scales 
openings  at the site of penetration  were two or three times larger than the diameter 
of the microorganisms. 
The cells in the stratum corneum  which are involved had an irregular ridge 
pattern  mainly composed of low broken undulating ridges which were sometimes 
branched. The surrounding uninvolved cells usually  possessed prominent villi that 
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resembled the surface structure of  the scale in psoriasis and other  parakeratotic 
disorders ( Dawber , Marks and Swift, 1972). 
This skin surface biopsy study showed that there was a remarkable 
difference between the numbers of bacteria seen in stained preparations with light 
microscope and scanning electron microscope. This is probably a reflection of the 
fact that the surface showed by scanning microscope is five or six cell layers down 
into stratum corneum , while  the light microscope shows the whole thickness of the 
specimen removed . 
Montes, Black and McBride (1967)  demonstrated that the great majority of 
microorganisms of erythrasma  does not invade  beyond the superficial part of the 
stratum corneum  by conventional electron microscope  [20]. 
The surfaces of the horn cells penetrated by the micro organisms possessed a 
disorganized ridge pattern that suggests a possibility of disruption of the 
tonofilament desmosome complexes. At the site of penetration , the opening was 
wider  than the micro organisms. This suggests that penetration was usually 
accomplished by a chemical dissolution rather than  physical pressure. 
Montes et al. (1967) noted there was disorganization of keratin fibrils in horn 
cells invaded by C.minutissimum. The enzyme reaction products showed 
aggregations in well defined areas confirming a complex subcellular arrangement 
akin to mammalian cells. Also a similar arrangement has been noted with enzyme 
reactions in the dermatophyte fungi (Meinhof, 1968). 
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The smooth exterior of the organism observed by scanning electron 
microscope showed only a slight constriction at the site of the junctions between 
microorganisms in chains . The  PAS reactivity of the microorganisms reflects the 
secretion of  mucopolysaccharide sheath by the organism in some situations. 
Somerville (1972) discussed the microbiology of cutaneous diphtheroids and  
stated that the diphtheroids responsible for trichomycosis axillaris produced 
secretions that stick them together and to the hair along with destruction of the hair 
keratin. A similar material  might be produced by C.minutissimum [12]. 
Tissue Culture Medium 199 for growing the organisms under specific 
conditions was devised by Sarkany, Taplin and Blank  [4]. This medium consist of 
78% tissue culture medium without bicarbonate, 20% fetal bovine serum and 2% 
agar. The prepared medium being autoclaved for 10 mts at 15 lbs pressure per 
square inch. Plates were poured by decanting the hot liquid from the coagulated 
proteins which are discarded. On inoculation at 38 ̊ C, the fluorescent scales of 
erythrasma lesions shows small shiny, round, translucent, colourless, slightly 
elevated convex colonies within 24-48 hours. There is no pigment production in 
visible light, although a red fluorescence diffusing into the surrounding medium can 
be observed under Wood’s light. Some batches of fetal bovine serum shows an 
inhibitory effect on the growth of the organisms . Autoclaving the medium or using 
a dialysate of fetal bovine serum will promote the growth and fluorescence. 
Inhibition of growth  can also take place, when autoclaved medium 199 is used with 
human or horse serum.  
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Certain batches of Tissue Culture Medium 199 are marketed with the added 
antibiotics such as penicillin or streptomycin. Such media are unsuitable as they 
suppress the growth of the organisms . A pink fluorescence in and around the 
colonies can be seen on sheep blood agar, chocolate agar and yeast extract casein 
agar, but the fluorescence assumes striking proportions only on the tissue culture 
medium. Subculture of the organisms can be done on a large number of 
bacteriological media. They can also thrive on the chorioallantoic membrane of ten 
day old embryonated eggs at 38 ̊ C. 
Gram stain of a smear from a colony shows Gram positive rods but appears 
pleomorphic in older cultures. These organisms are non-motile, aerobic or 
microaerophilic. They are catalase positive, indole negative , contain metachromatic 
granules and do not show hemolysis. They ferment  fructose, mannose, maltose and 
in some strains sucrose. Dark field microscopy shows typical bacilli with a marked 
thick outer wall and well rounded ends . In vitro sensitivity tests carried out on solid 
and liquid media showed  maximal sensitivity to erythromycin. 
Sarkany and his colleagues used pure culture to stripped or scarified areas of 
skin of forearms and kept them occluded for 72 hrs. Scaling and fluorescence were 
seen in three out of five inoculations. These were of relatively short duration and 
did not develop into permanent erythrasma. Fluorescent cultures also were 
reobtained from these experimentally induced lesions. Hence Sarkany et al. showed 
that this organism fulfill the criteria of  Koch's postulates [1]. 
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The grouping scheme proposed by Somerville shows that any of the seven 
groups of fluorescent diphtheroid might be isolated from the lesions of erythrasma . 
Using this grouping scheme Somerville and her colleagues found that in their 
community, one particular group which represent endemic strain was more 
commonly associated with erythrasma than with healthy skin . Group 2  was the 
initial isolate described by Sarkany, Taplin and Blank and used as type strain in the 
National collection of type culture [ 4]. 
It is clear that fluorescent diphtheroids associated with erythrasma are 
members of normal skin flora which eventually produce the characteristic 
fluorescing lesions of erythrasma and  multiply under certain conditions like 
chafing ,  maceration in axilla and groins to become predominant members of the 
skin flora . Non fluorescent diphtheroids also appear in great numbers in these 
lesions rather than on healthy, non scaling, non fluorescing areas. So  these 
conditions favour the multiplication of all type of  skin diphtheroids. 
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PATHOGENESIS 
The skin  along with mucous membrane forms the first line of defense 
against infection. Both keratinization and dryness limit the proliferation of 
microorganisms which is supported by low pH of skin surface [21]. These 
characteristics limit the colonization of  commensal  organisms . Microorganisms  
causing any skin infections need to overcome the above defense mechanisms. These 
organisms enter through an intact epidermis either  by  lysing the keratinocytes or  
mechanically destroying it. Some organisms look continuously  for an opportunity 
to get under  the epithelium through a break in epidermis which is usually 
traumatic. 
The stratum corneum consists of mainly keratin mixed with lipids secreted 
by different skin appendages. These  lipids  are used as substrate for metabolism by 
the organisms that parasitise on the skin which are mostly commensals[22] . Often 
their presence goes unnoticed until there is enough substrate available for them to 
outgrow in numbers evoking an inflammatory response of underlying tissue. This 
results in itching with or without erythema . Erythrasma  is one such disease that 
originate almost exclusively from skin folds where the concentration of secretory 
glands are highest  [23]. 
Thus the  corynebacterium minutissimum which is a commensal being 
lipophilic produces lesions predominantly involving flexures and  outgrows in 
number due to excessive sweating and maceration. 
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Corynebacterium species other than C.diphtheriae are known to produce 
severe and life threatening infection . There have been no previous reports of deep 
tissue invasion by Corynebacterium minutissimum except one study by Stephen A 
Berger et al. which reports  recurrent breast abscesses caused by Corynebacterium 
minutissimum in one of his patients [24]. There was no evidence suggestive of 
erythrasma in the patient but had skin disruptions. Local trauma might have served 
as the portal of  entry leading to invasive infections. 
CLINICAL FEATURES 
The common sites of involvement are groin, upper thigh, scrotum, axillae, 
pubis, inguinal folds, inframammary areas and toe webs. In toe webs, infection is 
chronic being most commonly between 4th & 5th toe followed by 3rd and 4th toes 
[25]
. There may be scaling, maceration and fissuring. 
Cabo H et al (1983) have described a case of generalised erythrasma in a 
patient with Type II diabetes mellitus [26]. Well defined scaly, lamellar plaques in 
larger areas of trunk, proximal parts of limbs and breast folds may occur in 
generalised forms. Discoid form [27] of erythrasma  with circular scaling patches are 
easily confused with pityriasis versicolour, pityriasis rotunda and psoriasis. This 
form being also called as tropical erythrasma [28].  Tschen JA and Ramsdell WM in 
1983 presented a case of disciform erythrasma . It was clinically characterised by 
surface with atrophy and diagnosis was made with help of Wood's light 
examination and Gram stain. 
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The  classic form  appears  as punctate, well circumscribed, maculopapular 
lesions with furfuraceous or greasy scales. Older lesions have fine scaling with 
serpiginous advancing ends . The colour of lesion depends upon  duration  and  
underlying skin pigmentation. It is  pink  in colour initially later changes to brown 
without central clearing. Occasionally vesiculation of lesion was reported by 
Grigoria and J.Delacretaz in interdigitoplantar type of erythrasma [29]. Pruritus is 
followed by vesiculation in the lesions. The lesions are initially vesicles with 
erythema followed by large bullae which contains yellow fluid which becomes 
opalescent later.  Rarely lesions may become eczematous. Many of the lesions were 
asymptomatic  and  patients seek medical attention for cosmetic disability. 
Occasionally these lesions are very itchy. Recurrence and chronicity  are noted in 
many cases.  A.Bowyer & McColl described  association of  erythrasma  with  
pruritus ani [ 9]. The longstanding  pruritus was cured with erythromycin . 
Negroni P [30]in 1976  reported that  toe nails may be involved in erythrasma  
with subungual hyperkeratosis and onycholysis. Shelley WB and Shelley ED (1982) 
studied the corynebacterial triad conisting of coexistent erythrasma, keratolysis 
punctuata and trichomycosis axillaris. They showed that trichomycosis axillaris 
caused by Corynebacterium tenuis and keratolysis punctata caused by 
Corynebacterium taplin were associated with erythrasma in few patients [31]. 
Few systemic infections can also occur due to Corynebacterium 
minutissimum. Corynebacterium minitissimum bacteremia in a patient with a 
chronic myeloid leukemia in blast crisis was reported by  Guarderas J and A.Karnad 
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(1986)[32]. Brian H.J. and Brucker A.J reported embolic retinopathy due to 
C.minutissimum endocarditis  in 1985 [ 33].                                      
Alfred Gorea and Stephen A Berger  in 1984  reported recurrent breast 
abscesses caused by C.minutissimum. The systemic infections that can occur due to 
C.minutissimum are 
i) infective endocarditis in valvular heart disease patients 
ii) septicemia in neutropenic patients  
iii)  post surgical wound infections 
iv)  recurrent abscesses. 
INVESTIGATIONS 
i) Wood’s lamp examination: 
Wood’s lamp is a high pressure mercury lamp with a special filter that 
allows the emission of a largely monochromatic UV light with a wavelength of 365 
nm 
[27]
. It is especially useful in the diagnosis of certain bacterial and fungal disease 
and in the assessment of  pigmentary disorders. 
For examination, the room should be completely darkened with the patient 
totally undressed. Lesions caused by Microsporum canis, M.audouinii and 
M.ferrugineum are identified by their blue-green fluorescence. Pityriasis versicolour 
lesion  shows a golden yellow fluorescence. Pseudomonas aeruginosa lesions give 
rise to a blue colour. 
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Depigmentation or hypopigmentation are more easily detected with the aid 
of Wood’s lamp. In patients suspected of having porphyria, urine, stool and red 
blood cells are screened with Wood’s lamp provoking a characteristic orange-red 
fluorescence. 
In erythrasma the suspected lesions when examined with Wood's light show 
coral red fluorescence due to porphyrin production by corynebacterium 
minutissimum. 
An extensive work on fluorescence with Wood's light was done by Wigger 
Alberti N and Elsner P in 1997  and they showed that if the lesions are washed with 
antibiotic soaps before Wood’s lamp examination, fluorescence may be transiently 
absent [34].  Sometimes fluorescence may persist even after treatment of erythrasma. 
A case of non fluorescent erythrasma of the vulva  was described by Mattox TF and 
Rutgers J (1993)  which was diagnosed by Gram stain and culture [35]. 
Other lesions which give pink fluorescence under Wood’s lamp examination 
are 
i. Normal tongue 
ii.  Necrotic tumors 
iii.   Openings of follicles of face and upper trunk 
iv.  Acanthosis nigricans of groin and axilla 
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2. Direct Examination: 
a)  Gram stain: 
The scales from the lesion are scraped and fixed to the slide using egg 
albumin. Alternatively Padilha (1996) described a single method to stain  
C.minutissimum and Malassezia furfur in scales collected on scotch tape with 
lactophenol cotton blue [36]. On staining Gram positive filamentous and coccoid 
forms were seen.  
b)  10% KOH preparation: 
           10% KOH solution is added to the scrapings from the lesion and examined 
under light  microscope. Chains of rods are seen. 
c) Culture 
Culture is difficult but rarely necessary and may be accomplished with a 
special medium the ideal one being Tissue culture medium 199. Simple mediums 
for pigment production by erythrasma diphtheroid  were described by Stephen N 
Cohen and Dorothy Nicholai in 1969  [37]. 
The scales of erythrasma lesion on inoculation at 38̊ C for 24-48 hours shows 
smooth small shiny translucent convex colonies . These colonies can fluoresce for 
upto 4 days under Wood’s lamp. Gram stain of smear from a colony shows Gram 
positive rods in freshly prepared cultures, later become pleomorphic in older 
cultures. 
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d) Skin biopsy: 
Biopsy of erythrasma lesion usually appears normal. It is described as one of 
the examples of invisible dermatoses. Small coccobacilli might be seen in the 
superficial layers of stratum corneum [38]. Though difficult to visualise under 
Hematoxylin and Eosin stain, special stains like  Gomoris Methanamine silver stain 
and Periodic Acid Schiff will reveal these coccobacilli. 
e) Others 
Investigations for underlying factors such as diabetes  mellitus, obesity and 
hypothyroidism should be carried out. 
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DIFFERENTIAL DIAGNOSIS 
1.  Pityriasis versicolor – chromic type 
The primary lesion is a sharply demarcated  macule  which is characterised  
essentially by fine branny scaling. Typically the eruption shows large confluent 
areas, scattered oval patches and outlying macules. Most commonly upper trunk 
which is rich in seborrrheic secretion gets affected but can spread to upper arms, 
axillae , groins and abdomen [40]. The scaly lesions under Wood’s lamp may  show  
pale yellow fluorescence. In these cases,axillary vault will not be involved. 
2.  Bacterial Intertrigo 
           It is an inflammatory condition of opposing  skin surfaces characterized by 
erythema , oozing , maceration and crusting [39]. Vesicles and  pustules may herald 
the infection. Triggering factors  include  perspiration, friction, maceration or 
irritation  from stool, urine or topical agents. KOH examination, Gram stain and 
culture help to identify the organism. 
3.  Candidal intertrigo 
           Most cases of cutaneous candidosis occur in skin folds which are occluded 
by clothing or shoes producing abnormally moist conditions. Clinically presents 
with erythema, cracking and maceration. Lesions have an irregular margin with 
surrounding satellite papules and pustules. 10% KOH preparation reveals yeast and 
pseudohyphae. 
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4. Tinea cruris 
           It manifests as large plaques of erythema with central clearing centered on 
the inguinal creases and extend distally down the medial aspect of the thighs with 
scaling at the periphery. 10% KOH examination reveals septate branching hyphae 
with arthrospores. Woods lamp examination is negative unlike erythrasma. 
5. Inverse pattern psoriasis 
Psoriasis is a chronic, relapsing inflammatory keratinization  skin disorder 
with  a strong genetic basis characterized by circular to oval erythematous plaques 
over extensor body surface and the scalp. Inverse psoriasis is a variant of psoriasis 
that spares the typical extensor surfaces and affects intertriginous areas with 
minimal scaling. Skin biopsy confirms the diagnosis. 
6.  Flexural seborrheic dermatitis 
Seborrheic dermatitis is a papulosquamous inflammatory disorder  occurring  
on sebum rich areas of scalp, face, upper trunk characterized by greasy  scaling over 
erythematous skin. The flexural variants are non scaly lesions occurring in  axillae,  
perineum or anogenital crease,  inframammary and inguinal folds. 
7. Contact Dermatitis 
Allergic and irritant contact dermatitis may mimic erythrasma. Irritant 
contact dermatitis manifests as erythema and hyperkeratosis but allergic contact 
dermatitis presents as pruritic papules and vesicles on an erythematous base. 
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Bacterial culture and 10% KOH examination are done. Patch test helps to diagnose 
contact allergens. 
8. Acanthosis nigricans 
It is characterised by symmetrical hyperpigmented velvetty  plaques most 
commonly on the intertriginous areas of the neck, axillae and groin.  Skin biopsy is 
the useful aid in the diagnosis. 
9. Pityriasis rotunda 
A case of pityriasis rotunda mimicking  erythrasma was reported  by Gupta S 
(2001)  [41]. It is a rare disease characterized by perfectly round to oval  sharply 
defined,  hypo or hyperpigmented patches over trunk and extremities with mild 
scaling. 
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TREATMENT 
The organism involved in this disease are sensitive to many antibiotics. 
Erythromycin was first suggested  by Sarkany et al for treatment of erythrasma. 
Erythrasma responds to keratolytic preparations and antimicrobials, but toe web 
infections are difficult to cure [42]. 
Erythrasma responds well to topical agents like 2% sodium fusidate, 
Whitfield’s’s’s ointment, tolnaftate, 1 to 2% clotrimazole,  miconazole , 10 - 20% 
aluminium chloride and 2% clindamycin hydrochloride.   
Clinical clearance and disappearance of red fluorescence after 2- 3 weeks in 
eight patients treated with tolnaftate with no relapses was acheived by Ayres and  
Mehan (1968) . In 1970 Macmillan  and Sarkany proved that sodium  fusidate to be 
effective particularly in the removal of fluorescent diphtheroids but it was not more 
effective than Whitfield’s ointment in producing resolution of clinical lesions. 
Seville and Somerville found that Whitfield’s ointment was more or less equally 
effective. Gaylon and Lonnor B.C in 1973 showed that Whitfield’s’s ointment  and 
clotrimazole were shown to be equally effective .  
Topical clotrimazole and tolnaftate lead to resolution of lesions mostly 
associated with dermatophyte infections. Also topical nadifloxacin and 
clarithromycin can be used. Topical erythromycin has not been consistently 
effective.  
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Koorshad  studied  adult male population and found out antibacterial soap 
was effective in the prophylaxis and control of erythrasma of toe webs. The 
vigorous use of any soap under trial conditions reduced the incidence of erythrasma, 
but the antibacterial soaps are more effective and better in reducing the amount of 
scaling was demonstrated by Somerville, Seville and Noble (1970).  Benzoyl 
peroxide or povidone iodine soaps when showering and powders after drying  are 
also effective. 
Systemic erythromycin in consistently effective in doses of  250mg qid for 5 
days by some and for 10 - 14 days by  others. Holdiness MR (2002) showed that in 
patients with involvement of axilla and groin,  systemic erythromycin when 
compared with tetracycline has greater efficacy [43].  Griseofulvin and penicillin are 
ineffective.  Erythrasma can be treated  with1gm single doses of clarithromycin was 
demonstrated by Wharton JR and Wilson PL (1998)[ 44] . 
Photodynamic therapy using red light (broadband, peak at 635 nm) has been 
reported to clear erythrasma in 23% of 13 patients and  improved erythrasma in the 
remaining patients [ 59]  . 
In a recent susceptibility study of 40 patients, several antibiotics were tested  
including penicillin G, ampicillin, cefaclor, amoxicillin-clavulanate, ampicillin-
sulbactam, tetracycline, erythromycin , ofloxacin, fusidic acid, levofloxacin and 
azithromycin. The study revealed statistically significant resistance to erythromycin, 
azithromycin, penicillin and ampicillin. Significant susceptibility was statistically 
found to amoxicillin-clavulanate,  cefaclor and fusidic acid[ 60]. 
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In a large double-blind, placebo-controlled, randomized trial, 151 patients 
older than 18 years were randomized into 5 groups and were given either 
erythromycin, single-dose clarithromycin, topical fusidic acid, placebo cream or 
placebo tablets. Fusidic acid cream was significantly more effective than other 
therapies. Additionally, the group who received clarithromycin did better at 48 
hours than did the group that received erythromycin. However, there was no 
statistical difference on day 7 and day 14 [ 61].  
Because culture and antibiogram are not performed routinely in daily clinical 
practice, the recommended initial topical treatment is fusidic acid cream. If this 
drug is not available, then topical erythromycin solution may be an alternative. In 
cases of topical treatment failure, erythromycin, single-dose clarithromycin, or 
amoxicillin-clavulanate should be chosen for the systemic treatment [60].  
Prognosis: 
Excellent, however recurs if predisposing factors are not eliminated. 
Prevention:  
 Bathe or shower often 
 Keeping skin dry 
 Wear clean clothes that absorb moisture 
 Avoid very hot or damp conditions 
 Maintain a healthy body weight 
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CLOTRIMAZOLE 
It is an azole antifungal  which belong to imidazole group. 
Mechanism of action 
Clotrimazole interacts with 14-α demethylase, a cytochrome P-450 enzyme 
that converts lanosterol to ergosterol, an essential component of the membrane of 
the yeast [45] and inhibits ergosterol synthesis, resulting in increased cellular 
permeability. It may also inhibit endogenous respiration, interact with membrane 
phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake 
of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the 
movement of calcium and potassium ions across the cell membrane by blocking the 
ion transport pathway known as the Gardos channel. 
Absorption 
Absorption of clotrimazole is less than 0.5% after application to the intact 
skin; from the vagina, it is 3% to 10%.  The small amount  absorbed is metabolized 
in the liver and excreted in bile [45]. 
Drug interactions 
There are no known significant drug interactions with topical clotrimazole. 
However, with oral (troche) clotrimazole, there are multiple interactions as the 
medication is a CYP450 enzyme inhibitor, primarily CYP3A4. Thus, any 
medication that is metabolized by the CYP3A4 enzyme will potentially have 
elevated levels when oral  clotrimazole is used [46]. 
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Side effects 
In a small fraction of recipients, clotrimazole on the skin  may cause 
stinging, erythema, edema, vesication, desquamation, pruritus and urticaria [45]. 
When it is applied to the vagina, about 1.6% of recipients complain of a mild 
burning sensation and rarely of lower abdominal cramps, a slight increase in urinary 
frequency, or skin rash. Occasionally, the sexual partner may experience penile or 
urethral irritation. By the oral route, clotrimazole can cause gastrointestinal 
irritation. In patients using troches, the incidence of this side effect is about 5%. 
Antimicrobial activity 
Clotrimazole is active against dermatophytes, molds ,fungi of the genus 
Candida and  Malassezia furfur. This drug is also active against Corynebacterium 
minutissimum, Streptococcus spp., Staphylococcus spp. and Trichomonas 
vaginalis[47]. 
Trials in erythrasma                 
A double-blind trial was used to compare the efficacy and acceptability of 
topical treatment with clotrimazole cream or Whitfield’s’s ointment for ringworm, 
pityriasis versicolour, and erythrasma infections and that of clotrimazole cream or 
Nystatin ointment for Candida infections. Clotrimazole was found to be as effective 
and acceptable as Whitfield’s's ointment and Nystatin ointment. 
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A clinical double-blind trial of topical miconazole and clotrimazole creams 
was carried out against superficial fungal infections of the skin. The trial showed 
both compounds to be very effective against dermatophytes, pityriasis versicolour, 
Candida and erythrasma infections. Patient acceptability was equally good for both 
compounds [64]   . 
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FUSIDIC ACID 
Fusidic acid is derived from the fungus Fusidium coccineum and was 
developed by Leo Laboratories in Copenhagen, with the most active derivative, the 
sodium salt (sodium fusidate), released for clinical use in the early 1960s [48]. 
Mode of Action 
A crucial stage in bacterial protein biosynthesis is the elongation phase, in 
which the nascent polypeptide grows as the ribosome moves along the mRNA in a 
stepwise fashion. Two elongation factors, EF-Tu and EF-G, are intimately involved 
in this process, with EF-G particularly associated with the translocation step in 
which the mRNA is advanced along the ribosome by 1 codon to allow the next 
round of polypeptide elongation to begin [49]. Fusidic acid blocks bacterial protein 
synthesis by binding to EF-G on the ribosome, thereby preventing release of the EF-
G—guanosine diphosphate complex and effectively stalling bacterial protein 
synthesis by inhibiting the next stage in translation [49–51]. The action of fusidic acid 
is mainly bacteriostatic but, at high concentrations, may be bactericidal. The gene 
encoding EF-G is fus A, which is chromosomally located.  
Antimicrobial activity 
Fusidic acid has good in vitro activity against staphylococci, including both 
methicillin sensitive and resistant strains. It also has useful activity against 
Neisseria spp, Bordetella pertussis, Corynebacterium spp, Gram positive anaerobes 
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such as Clostridium difficile and C.perfringens, Peptostreptococcus spp and 
Propionibacterium acnes 52. 
Pharmacokinetics  
Penetration of fusidic acid applied topically to the skin is minimal with 
studies showing absorption of 2% or less [53]. 
Distribution 
Fusidic acid has modest penetration into bone (16 – 24%) and  synovial fluid 
(28-88%) and achieves levels in pus that are marginally below those in serum. Skin 
exudate and burn studies show good Cmax values and high fluid/serum ratios [54]. 
Metabolism 
Hepatic metabolism with biliary excretion is the most likely route of 
elimination, although renal elimination of hepatic conjugates or metabolites has not 
been specifically reported. Examination of biliary metabolites of fusidic acid shows  
that the main metabolites are a glucuronide conjugate and a dicarboxylic derivative, 
accounting respectively for 15% and 10% of the drug in bile. A variety of minor 
metabolites are produced [54]. 
Topical Preparations  
There are three preparations- 2% fusidic acid cream, 2% fusidic acid 
ointment and 2% fusidic acid gel all for use on skin surfaces twice daily.  
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Skin Reactions 
Contact dermatitis occurs in some patients after topical use but is 
uncommon[55]. Often it has been associated with use in patients with stasis ulcers. 
Drug interactions 
Hepatic cytochrome P450 enzyme interactions have been described for 
fusidic acid. Levomethadone metabolism is increased during prolonged fusidic acid 
therapy due to induction of cytochrome P450 isoenzymes [56]. 
In erythrasma 
Sodium fusidate ointment has been used in the treatment of erythrasma in a 
mental hospital. In comparison with a benzoic acid (Whitfield’s) ointment it proved 
as effective in clearing fluorescent lesions (90%‚cure) and more effective in 
clearing the associated Corynebacterium minutissimum. It was, however, less 
effective in removing scaling [62]. 
In a Danish multi-practice study the efficacy of erythromycin tablets  500 
mgs , fusidic acid cream  and placebo was compared in 86 patients (71 men and 15 
women) with erythrasma. The patients were treated 'double-blind'  for 14 days with 
either active tablets + placebo cream, placebo tablets + active cream or placebo 
tablets + placebo cream. The signs of erythrasma, i.e. colour intensity, demarcation 
and scaling of the affected area, as well as degree of fluorescence under Wood's 
light, were recorded before treatment, after one and two weeks, and at follow-up 
four weeks later. Cure/improvement was obtained in 77% of the cases in the 
erythromycin group, 87% in the fusidic acid group and 42% in the placebo group. 
There was no difference between the active preparations [63]. 
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AIMS OF THE STUDY 
 
1. To study the age and sex distribution of the patient. 
2.  To study the clinical profile of erythrasma. 
3.  To study the predisposing conditions. 
4.  To study the association of other corynebacterial skin infections.  
5.  To compare the efficacy of topical 2% clotrimazole cream vs 2% fusidic acid 
cream in the treatment of  erythrasma. 
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MATERIALS AND METHODS 
 
50 cases of erythrasma were collected at random from the outpatients of 
Department of Dermatology, Chengalpattu govt medical college & hospital, 
Chengalpattu over a period of 1 year from Jan 2014 to Jan 2015for the study. 
Inclusion criteria   :  
1. All patients of either sex within age between 18 and 60 years 
2. Patients with clinically confirmed diagnosis of erythrasma. 
Exclusion criteria  : 
1. All patients of  either sex < 18  and >60 years 
2. Patients who were on  treatment with systemic or topical  antibiotics 
3. Patients who were on treatment with topical steroids. 
4. Known hypersensitivity to any of the components of the study 
medications  
5. Severe  hepatic, renal, and  systemic skin diseases. 
6. Pregnancy and lactation 
During Study 
1. If patient develops severe side effects/intolerant during the treatment 
2. If patient wants  alternate medicine during the study 
3.  If patient discontinues the treatment 
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With  informed consent the cases were chosen for the study with the clinical 
diagnosis. 
Subsequently careful history was elicited with particular reference to the 
following: 
(i) Age, Sex of patient 
(ii)  Symptoms and duration of disease. 
(iii)  Symptoms related to predisposing conditions. 
A detailed systemic and dermatological examination were done. 
Routine analysis of hemoglobin, urine, blood sugar, renal function tests, liver 
function tests were done in all patients. 
In appropriate cases thyroid function tests and  ELISA for HIV were done. 
           The skin lesions erythrasma were subjected to clinical examination and 
Wood’s lamp visualization. 
For Wood’s lamp examination the patient was asked to come without having 
bath. A portable Wood’s lamp was used. The patient was undressed in  a dark room 
and the lesions were examined under Wood’s lamp. 
The scales from the lesion were collected by scraping. Using egg albumin 
the scales were fixed on to the slide. The smears were then stained by Gram method 
and visualised under light microscopy. 
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In all cases culture was done. The site of the lesion was thoroughly cleaned 
and scraping was done. The scales collected were inoculated using a sterile 
platinum loop into a medium containing Mueller - Hinton Agar enriched with 
blood. The inoculated plates were incubated at room temperature for 48 hours. After 
48 hours the colonies which appeared were subjected to Wood’s lamp examination 
and  observed for coral red fluorescence. 
After the confirmation of diagnosis, 50 patients were randomnly divided into 
group A and group B with 25 patients in each. 
Group A were treated with 2% clotrimazole  cream and Group B with 2% 
fusidic acid cream  for  2 weeks. 
Comparison of  its efficacy was based on colour intensity , demarcation and 
Wood’s  lamp reflection score. 
EFFICACY PARAMETERS 
Efficacy of treatment was assessed by the percentage in reduction of colour 
intensity, demarcation, scaling and Wood’s lamp reflection score on 1st day , 7th day 
and 14th day with physician’s global assessment score. 
Grade 0 - worsened 
Grade 1 – nil  0-25% reduction 
Grade 2 – mild improvement -26-50% reduction 
Grade 3 - moderate improvement -50-75%reduction 
Grade 4 - marked improvement  -76-100% reduction 
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           The response rate {% reduction in colour intensity, scaling  and 
demarcation} was assessed during every follow up. 
Wood’s lamp reflection score 
Score 2- prominent red fluorescence 
Score 1 – mild red fluorescence 
Score 0 – no fluorescence 
These score values are considered as follows complete response 0. 
Partial response 0.5-1, no response 1.5 -2. 
Statistical Analysis  
All variables were examined for outliers and non-normal distributions. The 
categorical variables were expressed as frequency and percentage. The quantity 
variables were expressed as mean and standard deviation. Descriptive statistics 
were used to evaluate baseline characteristics .The group comparison for the 
categorical variables were analyzed using chi – square test and for quantity 
variables were analyzed using Analysis of Variance (ANOVA) and Independent 
student t test (or Wilcoxon rank sum test when hypothesis of normality was 
rejected). p - value of less than 0.05 was considered as statistically significant. The 
statistical analysis was carried out using statistical software SPSS 19.0.  
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OBSERVATIONS & RESULTS 
 
 
Sex distribution 
Of the 50 cases of erythrasma studied 22 were males and 28 were females. 
The incidence of males was 44% and females was 56%. 
 
Following bar diagram shows percentage of sex distribution  
. 
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Age distribution 
Age distribution in the study varied from 18 yrs to 60 yrs. 
 
Table - I Age distribution 
Age in years No. of cases Percentage 
20 – 30 2 4 
30 - 40 10 20 
40 -50 25 50 
50 - 60 13 26 
Total 50 100 
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GRAPH SHOWING AGE DISTRIBUTION 
 
 
 
50% of the cases were in the age group of 40- 50 years. 
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Symptoms 
Itching and discolouration of the flexures were the predominant symptoms of  
erythrasma. 
Table 2 - symptoms 
Symptoms No. of cases Percentage 
Itching 10 20 
Discolouration 18 36 
Both 22 44 
Total 50 100 
 
44% of the cases presented with both itching and discolouration. 
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GRAPH SHOWING SYMPTOMS 
 
 
 
36 % of the cases presented with cosmetic problem of discolouration. 
22% of the cases presented with itching alone. 
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Duration of the disease 
 In 72% of cases the duration of disease varied between 6 months and 2 years. 
 
Table 3- duration 
Duration in years No. of cases Percentage 
0 – 0.5 8 16 
0.5 - 1 30 60 
1 -1.5 8 16 
1.5 - 2 4 8 
Total 50 100 
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GRAPH  SHOWING DURATION OF LESION 
 
  
 
Maximum number of patients showing duration between 6months – 1year. 
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Colour of  the lesion 
The various colours of erythrasma lesions observed  
 
Table - 4 Various colours of the  lesion observed 
Morphology No. of cases 
Reddish brown 44 
brown 3 
black 3 
 
Majority were of  reddish brown. 
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GRAPH SHOWING COLOURS OF  THE LESIONS 
 
 
 
 
Majority of the cases observed were reddish brown ( fig :1 ).The remaining 
small percentage  of  brown ( fig :2 ) and black type. 
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Distribution of lesions  
 
Table 5 – Distribution of lesions 
Distribution No. of cases 
Axilla 44 
Groin 46 
Inframammary 4 
 
Most of the people had groin involvement [ fig 2] followed by axilla [ fig 3]. 
A  few  presented with  inframammary area involvement [ fig 4]. 
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GRAPH SHOWING  DISTRIBUTION OF LESIONS 
 
 
 
Majority of the patients showed groin involvement. 
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Associated corynebacterial infections. 
Keratolysis punctata  [fig 5] was seen in 5 of the cases and trichomycosis 
axillaris [ fig 6] in two of  the patients . 
 
Table 6 – associated corynebacterial infections 
Infections No. of cases percentage 
Keratolysis punctata 5 10 
Trichomycosis axillaris 2 4 
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GRAPH SHOWING NUMBER OF CASES ASSOCIATED WITH OTHER 
CORYNEBACTERIAL INFECTIONS 
 
 
 
Other corynebacterial infections can be associated. 
  
0
2
4
6
8
10
12
keratolysis
punctuata
trichomycosis
axillaris
percentage
53 
 
 
Associated systemic conditions 
Among systemic conditions, obesity  was associated with 60 % of  cases. 
Diabetes mellitus  was associated with 50% of cases and hypothyroidism in 20 % of 
cases. 
 
Table 7–associated systemic diseases. 
Systemic diseases No. of cases Percentage 
Obesity 30 60 
Diabetes mellitus 25 50 
Hypothyroidism 10 20 
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GRAPH SHOWING PERCENTAGE OF CASES ASSOCIATED WITH 
SYSTEMIC DISEASES 
 
 
 
Majority are associated with obesity. 
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Other skin lesions associated with erythrasma                                   
As obesity was a major factor associated, patients also presented  with 
acrochordons [ fig 7] and acanthosis nigricans. Among 50 patients,  15 patients had 
skin tags and  8 patients had acanthosis nigricans. 
 
Table 8- associated skin lesions 
Skin lesions No. of cases Percentage of cases 
Acanthosis nigricans 8 16 
Acrochordons 15 30 
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GRAPH  SHOWING ASSOCIATION WITH OTHER SKIN LESIONS 
 
 
 
30 % associated with acrochordons and  16 % associated with acanthosis nigricans. 
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INVESTIGATIONS 
Complete Hemogram 
In 50 cases recorded, anemia was seen in 5 cases leukocytosis was seen in 7 
patients. 
Blood Sugar : 15  cases showed hyperglycemia which were later confirmed by 
glucose tolerance test.10 cases revealed diabetes mellitus. 
Blood cholesterol: 5 cases were associated with hypercholesterolemia. 
Thyroid Function test: Revealed hypothyroid status in 10 cases. 
Elisa for HIV  : positive in 3 cases. 
Wood’s lamp Examination : Portable Wood’s lamp was used. The patient was 
advised to come without having bath. Coral red fluorescence (Fig 9 ) was observed 
in all. 
Gram Stain: The scales were scraped and fixed on to slide using egg albumin and 
stained by Gram method. Gram positive coccobacilli were seen in all cases (Fig 10). 
Skin biopsy 
Histologically there was hyperkeratosis with basket weave stratum  corneum, 
acanthosis and papillomatosis. There was increased pigment in the basal cell layer. 
Sparse inflammatory infiltrate was present in the upper dermis and around blood  
vessels. ( fig 11) 
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Culture 
The scales were collected and inoculated into a medium of Mueller Hinton 
Agar enriched with blood. Small pale grey convex colonies (Fig.12) appeared after 
48 hours in only 4 cases out of 50 cases inoculated. 
Treatment  
Among 50 cases with erythrasma, 25 patients treated with topical 2 % 
clotrimazole cream  and the remaining 25 patients with 2 % fusidic acid cream. In 
addition they were given antihistamines in case if itching is present. 
These patients are compared on the basis of colour intensity, demarcation, 
scaling and Wood’s lamp reflection scores on 1st , 7th and 14th day. 
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REDUCTION IN PERCENTAGE OF COLOUR INTENSITY  
Table 9- comparing reduction in percentage of colour intensity in two groups 
Day 
Group A 
2% clotrimazole cream 
Group B 
2% fusidic acid cream 
p value 
1 0
 
0 0 
7 50.32±17.64 64.85 ± 18.35 0.0064 
14 65.5Ͳ ±21.21 87.78±20.75 0.005 
 
In patients in Group A, at the end of 7th day there was 50% reduction in the 
colour intensity. At the end of 14th day the reduction in colour intensity was 84%. 
In  patients in Group B , at the end of 7th day there was 65 % reduction in 
colour intensity. At the end of 14th day, the reduction in colour intensity was 88%. 
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GRAPH SHOWING REDUCTION IN PERCENTAGE OF COLOUR 
INTENSITY 
 
 
This graph shows variation in the reduction of percentage of colour intensity in 2 
groups. 
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REDUCTION  IN  PERCENTAGE OF DEMARCATION  
 
Table 10-comparing reduction in percentage of demarcation in two groups 
Day 
Group A 
2% clotrimazole cream 
Group B 
2% fusidic acid cream 
p value 
1 0 0 0 
7 53.84±17.35 66.53±22.54 0.0304 
14 76.54±12.54 88.54±11.46 0.0009 
 
At the end of 7th day ,Group A showed  53 % reduction in percentage of 
demarcation  and at the end of 14th day they showed  76 % reduction in percentage 
of  demarcation. 
At the end of 7th day , group B showed 66 % reduction in percentage of  
demarcation and at the end of 14th day they showed 88% reduction in percentage of 
demarcation. 
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GRAPH SHOWING PERCENTAGE IN REDUCTION OF DEMARCATION 
 
 
 
This graph shows variation in percentage in  reduction of demarcation in the  
2 groups. 
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REDUCTION IN PERCENTAGE OF SCALING 
 
Table 11-comparing reduction in percentage of scaling in two groups 
Day 
Group A 
(2% clotrimazole 
cream) 
Group B 
( 2% fusidic acid 
cream) 
p value 
1st day 0 0 
 
7th day 28.5± 11.32 38.5 ± 12.51 0.0046 
14th day 58.32±  19.66 78.25 ±  15.62 0.0002 
 
Group A  show  29 % reduction on 7th  day  and 58 % on 14th day.  But 
group B showed  38% on 7th day and 58% reduction on scaling on 14th day. 
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GRAPH SHOWING PERCENTAGE OF REDUCTION IN SCALING 
 
 
 
This graph shows there was significant reduction in percentage of scaling 
between  group A and group B on 7th and 14th day of treatment. 
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REDUCTION IN WOOD’S LAMP REFLECTION SCORE 
 
Table 12-comparing reduction in Wood’s lamp reflection score 
Day 
Group A 
[2% clotrimazole 
cream] 
Group B 
[2% fusidic acid 
cream] 
p value 
1 2 2 
 
7 0.450±Ͳ.ͳͶͳ 0.032±0.032 0.001 
14 0.333±Ͳ.ͳͲͷ 0.016±Ͳ.Ͳͳ͸ 0.0001 
          
Group B showed statistically significant  reduction in Wood’s lamp 
reflection score on 7th day and 14th day  compared to Group A. 
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GRAPH SHOWING REDUCTION IN WOOD’S LAMP REFLECTION 
SCORE. 
 
 
 
In this score, group B was better. 
  
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
1st day 7th day 14th day
Group A
Group B
67 
 
 
 
SIDE EFFECTS 
Local side effects like erythema, burning sensation , hypersensitivity and 
allergic contact dermatitis may occur. But in the present study none of the side 
effects were observed. 
Tolerance of patients were good in both groups. 
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RESPONSE  TO THERAPY 
Table 13 –physician’s global response 
Grade Response 
2% 
clotrimazole cream 
2% 
fusidic acid cream 
Total 
0 worsened - - - 
1 Nil - - - 
2 Mild 2 - 2 
3 Moderate 8 4 12 
4 Marked 15 21 36 
 Total 25 25 50 
 
According  to this study, out  of 25 patients in Group A , 2 patients showed 
mild response , 8 patients showed moderate response and 15 patients show marked 
response. 
Out of 25 patients in Group B , 4 patients showed moderate response and 21 
patients showed marked response. 
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DISCUSSION 
Sex Distribution 
In this study , there were 28 female and 22 male patients showing that the 
incidence of erythrasma is more in females than in males. In literature erythrasma  
have equal sex incidence was reported by Gary L Darmstadt et al [28]  and it is more 
common in men by Peter K Lee et al [39].  This increased incidence may be due to 
the obesity commonly observed in females more than forty years. 
Age Distribution 
The most common age group  affected were between 40 - 50 years in which 
half  of cases occured. 48 cases (86%) occured in the 30 - 60 years age group.The 
youngest age group observed was 21 years and oldest was 60 years. 
This correlates with the literature that incidence of erythrasma increase with 
age as reported by Gary L Darmstadt et al [28 ] and Laube S [6]. 
The prevalence of metabolic derangements like diabetes mellitus, obesity 
and hypothyroidism  show an increase in middle age group which  might be the 
reason for the occurrence of erythrasma in them. 
Also the presence of lipid in apocrine secretion after puberty may also 
influence the above finding. 
Symptoms 
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In this study 22 patients (44%) had itching and discolouration of flexures as 
their predominant complaint. It was asymptomatic in 18 cases (36%) who reported 
for the cosmetic inconvenience. 
In temperate climates the erythrasma lesions were symptomless as reported 
by RJ Hay and BM Adrians [16]  but in tropics, irritation of lesions occur leading to 
scratching. 
The  increased sweating and maceration in the flexures due to obesity might 
be the reason for itching in majority of cases. 
Duration of disease 
It is shown in this study that erythrasma is a chronic disease and it has 
remissions and relapses. These relapses were associated with the hot and humid 
tropical climate due to increased sweating and thereby maceration. 
Presence of disease in family members 
12 patients (24%) had family members who were also diagnosed as 
erythrasma.This indicates that the disease is not  contagious but  the common living 
conditions and similar predisposing factors in families  results in the increased 
incidence of erythrasma among family members. 
Dermatological lesions 
In literature the most common type reported was the reddish brown type 
which was also the commonest in this study. It was seen in 44 patients (88%).  3 
patients with brownish  macular lesion and 3 with blackish coloured lesions.   
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Distribution of lesions 
In this study , groins were the most common site to be affected followed by 
axilla bilaterally and symmetrically. In literature also ,erythrasma was described to 
occur most commonly in the groins by RJ Hay and BM Adrians [15].  All the 
intertriginous areas were affected. 
Associated corynebacterial infections 
In this study,  dermatophytosis,  candidiasis and pityriasis versicolour  are 
ruled out. Only keratolysis punctata and trichomycosis axillaris were taken into 
account.  
Shelley et al in 1982 described the coexistence of erythrasma with pitted 
keratolysis and trichomycosis axillaris [31]. Concomitant erythrasma and 
dermatophytosis of groin was reported by Schlappner et al in 1979 [10]. In 2004, 
Karakatsanis G  was the one to describe the coexistence of pityriasis versicolour 
and erythrasma [11]. 
The coexistence of the above infections with erythrasma indicates that 
common predisposing factors of moisture and obesity are involved in these 
conditions. 
Associated systemic disorders 
The literature reports of  Haroon TS [13]  and Scheinfeld NS [15]  showed that 
the increased frequency of obesity and diabetes in the patients associated with  
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erythrasma .This may be related to the high levels of cutaneous free glucose 
occuring in diabetes mellitus.  
The association of hypercholesterolemia in 5 patients (10%) in the study 
group suggests that an increase in cutaneous lipid may possibly promote the growth 
of lipophilic Corynebacterium minutissimum. 
Hypothyroidism and obesity may be the underlying cause in them which 
may predispose to erythrasma. 
The association of thyroid disorders and diabetes suggest that a possible  
autoimmune mechanism may play a predisposing role to erythrasma. 
Investigations 
Anemia was recorded in 5 cases and leucocytosis was seen in 7 cases. There 
was no reactive leucocytosis as this bacteria is usually not invasive  and remains 
mainly in stratum corneum. 
The literature states that erythrasma prevalence is not increased in 
immunosuppressed patients [42]. Only  3 cases were positive for HIV by ELISA in 
this study. 
Specific investigations 
The procedures  like Wood’s lamp and Gram stain smear were the one to 
prove that etiological agent is Corynebacterium minutissimum by demonstrating its 
coproporphyrin production by coral red fluorescence and visualization of gram 
positive coccobacilli. 
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These two tests gave consistently positive results in almost all cases and the 
diagnosis of erythrasma was confirmed following which they were taken for 
therapeutic study. 
Treatment 
Though both  topical 2% clotrimazole cream and 2% fusidic acid cream 
showed greater reduction in colour , intensity and Wood’s lamp reflection score in 
erythrasma. At the end of  2nd week , 2% fusidic acid cream showed significant 
reduction in intensity, demarcation and Wood’s lamp reflection score. 
In a double-blind, placebo-controlled study in which oral erythromycin and 
topical 2% fusidic acid cream were used in 86 cases of erythrasma, it was found that 
the rate of complete response was 77% in the erythromycin group, 87% in the 
fusidic acid 2% cream group and 42% in the placebo group, and no statistically 
significant difference was found between these treatment modalities  [57]  . In another 
study, a twice-daily 14-day application of 2%  fusidic acid cream  had the success 
rate of up to 89%, and no recurrence was seen in the 40th post-treatment week  [58 ]  . 
In the present study , the reduction in  colour intensity from baseline to 2 
weeks was significantly greater in 2 %fusidic acid than 2 % clotrimazole cream 
{89% vs 76% }.Though  both the groups showed reduction in colour intensity, rapid 
onset of reduction with  in first week was shown by 2% fusidic acid cream. 
The reduction in demarcation from baseline to 2 weeks was significantly 
greater in 2% fusidic acid cream than 2 % clotrimazole cream { 86% vs 66%}. 
Reduction  in demarcation was rapid in the group of 2% fusidic acid cream. 
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The reduction in percentage of scaling from baseline to 2 weeks was 
significantly greater in 2% fusidic acid cream than 2% clotrimazole cream  { 78% 
vs 58%}. Reduction was greater with 2% fusidic acid cream. But compared to other 
parameters ,the reduction in percentage of scaling was much lesser. 
The reduction in Wood’s lamp reflection score was significantly greater in 
2% fusidic acid cream than 2% clotrimazole cream .Wood’s lamp reflection score 
was almost zero in 1st week itself or 2% fusidic acid cream. In Oktay vaci et al 
study , 2% fusidic acid cream showed almost complete reduction in Wood’s lamp 
reflection score [61]. 
Response of treatment to 2 % fusidic acid cream and 2% clotrimazole cream 
was moderate to marked . But marked response was seen in increased number in 
group of 2 % fusidic acid cream compared to 2% clotrimazole cream. Few patients 
in 2% clotrimazole cream show mild improvement. 
Side effects like burning sensation, irritation or allergy contact dermatitis 
was not observed in any of the study groups. Compliance and tolerance were good 
in both groups. 
In general , topical 2% fusidic acid cream was found to be more effective 
than 2% clotrimazole cream in patients with erythrasma. It shows that antibacterial 
activity is more with 2% fusidic acid cream compared to 2% clotrimazole cream.  
Topical 2% clotrimazole cream is effective when there is associated fungal 
infection. Patients  were taken for study after ruling out fungal infections and hence 
the decreased efficacy of 2% clotrimazole cream. 
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                                  CONCLUSION 
The following conclusions were drawn through the study regarding 
erythrasma 
1. More  common in females. 
2. More common in the age group 40 -50 years. 
3. Duration of lesions vary from 6 months to 2years. 
4. Discolouration and  itching  were the predominant symptoms. 
5. Morphologically reddish brown macular lesions are common. 
6. Groin is the most common site of involvement. 
7. Other corynebacterial infections like keratolysis punctata and trichomycosis 
axillaris could be associated. 
8. Systemic disorders like obesity .diabetes mellitus and  hypothyroidism could be 
associated. 
9. Gram stain and Wood’s lamp examination were more useful aids in diagnosis. 
10. 2 % fusidic acid cream was effective than 2% clotrimazole cream in its 
treatment. 
11. Tolerance and compliance were good in both 2% fusidic acid cream and 2% 
clotrimazole cream. 
12. Efficacy was seen rapidly with 2% fusidic acid cream. 
13. Antibacterial activity towards corynebacterium minuttismum was more with 
fusidic acid than clotrimazole. 
1 
 
FIGURE - 1 
 
 
FIGURE - 2 
 
2 
 
FIGURE - 3 
 
 
FIGURE - 4 
 
3 
 
FIGURE - 5 
 
 
FIGURE - 6 
 
4 
 
FIGURE - 7 
 
 
FIGURE - 8 
 
5 
 
FIGURE - 9 
 
 
FIGURE - 10 
 
6 
 
FIGURE - 11 
 
 
FIGURE - 12 
 
  
7 
 
FIGURE - 13 
 
 
FIGURE - 14 
 
8 
 
FIGURE - 15 
 
 
FIGURE - 16 
 
9 
 
FIGURE - 17 
 
 
FIGURE - 18 
 
10 
 
FIGURE - 19 
 
 
FIGURE - 20 
 
11 
 
 
REFERENCES 
1. Maibach HI, Raza A : Bacterial infections of skin in Moschella SL, Hurley JH 
(eds): Dermatology, Ed 3. Philadelphia, WB Saunders Co, 1992, pp 731 - 732. 
2. Kamalam. A, Thambiah. A.S., Bagavan das. M. and Govindaraju. S Mycoses in 
India-Study in Madras. Transactions of the Royal Society of Tropical Medicine 
and Hygeine 1981, Vol.75, 92-100. 
3. Marks. R, N.D. Ramnarain, B.Bhogal and N.T.Moore. The erythrasma micro   
organism insitu-studies using the skin surface biopsy technique. J. Clin. Pathol.    
1972 September, 25(9): 799-803. 
4. Sarkany I, Taplin D, Blank H. The etiology and treatment of erythrasma. .Invest     
Dermatol. 1961; Vol.37, pp.283-290. 
5. Sarkany I, Taplin D, Blank H. Incidence and Bacteriology of erythrasma. Arch   
Dermatol 1962 May; 85: 578-82. 
6. Laube S. Skin Infections and ageing. Ageing Res Rev 2004 Jan; 3(1): 69-89. 
7. Morales-Trujillo ML, Arenas R, Arroyo S. [Interdigital erythrasma: clinical,       
epidemiological and microbiologic findings]. Actas Dermosifiliogr. Jul-Aug       
2008;99(6):469-73.  
8. Holdiness MR. Erythrasma and common bacterial skin infections. Am Fam 
Physicians 2003 Jan 15; 67(2): 254. 
9. Bowyer A, Mc Coll I. Erythrasma and pruritusani. Acta Derm Venereol 1971; 
51(6) 444-7. 
12 
 
10. Schlappner OL, Rosenblum GA, Rowden G, Phillips TM. Concomittant  
Erythrasma and  dermatophytosis of groin. Br.J. Dermatol 1979 Feb; 
100(2):147-51 
11. Karakatsanis G, Vakirlis E, Kastoridou C, Devliotou-Pangiotidou D coexistence 
of pityriasis versicolour and Erythrasma. Mycoses 2004 Aug; 47(7):343-5. 
12. Somerville DA, Lancaster-Smith M. The anerobic cutaneous microflora of   
diabetic  subjects.  Br. J. Dermatol 1973, Vol.89; 395-400. 
13. Haroon TS , Diabetes and Skin-a review. Scott Med J. 1974 Nov. 19; 257-67. 
14. Montes LF, Dobson H, Dodge BG, Knowles WR. Erythrasma . 
15. Scheinfeld NS. Obesity and dermatology. Clin Dermatol 2004 Jul-Aug; 
22(4):303-9. 
16. Author RJ Hay and BM Adrians.Textbook of Dermatology Rook edited by Tony 
Burns, Stephen Breathnach, Neil Cox, Christopher Griffiths. 7th edition, Vol.2 
Bacterial infections.  
17. Sarkany I, Taplin16. Sarkany I, Taplin D, Blank H. Erythrasma-Common 
bacterial infection of skin JAMA 1961 Jul 15; 177; 130-2. 
18. Montes LF, McBride ME, Johnson WP, Owens DN, Knox JM. Ultrastructural  
study  of host  bacterium relationship in erythrasma. J. Bacteriol 1965 Nov;    
90(5):1489-91. 
19. Marks R. Keio. Seeing through the stratum corneum. J. Med. 2000 Jun. 49:80-3. 
20. Montes LF, Black SH, McBride ME. Bacterial invasion of stratum corneum in       
erythrasma, ultrastructural evidence of keratolytic action exerted by 
corynebacterium  minutissimum. J. Invest Dermatol. 1967, Nov; 49; 474-85. 
21. Hartmann AA. The influence of various factors on the human resident skin flora.    
Sem in Dermatol 1990 Dec. 9 : 305 - 8. 
13 
 
22. Noble W-C and Somerville D.A., Physical features p3-23; Corynebacteria as       
Pathogens; p-100-120, In: Microbiology of Human skin-London, Philadelphia,       
Toronto, Saunders, 1974. 
23. Golledge CL, Phillips G. Corynebacterium minutissimum infection. J. Infect        
1991, Jul 23: 73-6. 
24. Stephen A Berger, Alfred Gorea, Jona Stadler, Michael Dan. Recurrent breast       
abscesses caused by C.minutissimum. Journal of clinical. Microbiology, Dec         
1984, P.1219 - 1220. 
25. Andrews' diseases of skin-clinical dermatology; 9th edition Edited by Richard        
B.Odom, William. D.James, Timothy G.Berger. Bacterial infections Page 326. 
26. Cabo H, Franco de Montes de Oca N, Tzovanis Mc, Gallardo H. Generalised 
erythrasma. Med Cutan Ibera Lat Am 1983; 11(2): 129-32. 
27. Tschen JA, Ramsdell WM. Disciform erythrasma. Cutis 1983 May; 31(5): 541-
2,547. 
28. Pediatric Dermatology 3rd edition: Edited by Lawrence A.Schachner and 
Ronald C Hansen. Bacterial infections by Gary L. Darmstadt, Wesley king 
Galen and Gayle Fischer. Page 1036. 
29. Grigoriu D, Delacretaz J. Vesiculobullous erythrasma of feet. Dermatologica 
1976; 152(1): 1-7. 
30. Negroni P. Erythrasma of the nails. Med Cutan Ibera Lat Am 1976, 4(5):349-57. 
31. Shelley WB, Shelley ED. Coexistent erythrasma, trichomycosis axillaris and       
pitted keratolysis-an overlooked corynebacterial triad? J Am Acad Dermatol 
1982. Dec; 7(6): 752-7. 
14 
 
32. Guarderas J; A.Karnad, S.Alavarez, S.L.Berk. Corynebacterium minutissimum 
bacteremia in a patient with CML in blast crisis. Diag. Microbiol. Infect. Dis.      
1986, Vol.5, pp.327-330. 
33. Brian H.J; A.J.Brucker; 1985. Embolic retinopathy due to corynebacterium 
minutissimum endocarditis. Br. J. Ophthalmol, Vol.69, pp.29-31. 
34. Wigger Alberti W, Elsnor P. Fluorescence with Wood's light. Current 
applications in dermatologic diagnosis, therapy, follow-up and prevention. 
Hautarzt 1997, Aug 48: 523-7. 
35. Mattox TF, Rutgers J, Yoshimori RN, Bhatia NN. Nonfluorescent erythrasma of        
vulva. Obstet Gynecol 1993 May: 81(5): 862-4. 
36. Padilha - Goncalves A. A single method to stain Malassezia furfur and 
corynebacterium  minutissimum in Scales. Rev Inst Med. Trop. Sao Paulo 1996      
Jul-Aug 38 : 299 - 302. 
37. Stephen N Cohen, Dorothy Nickolai. Simple medium for pigment production by        
the erythrasma diphtheroid. Appl. Microbiol 1969 March; 17(3): 479-480. 
38. Skin pathology David Weedon 2nd edition. Bacterial and rickettsial  infection. 
Page 622. 
39. Fitz patricks Dermatology in General Medicine-6th Edition: Edited by Irwin M 
Freedberg (et al) Vol.2, Chap. 194, Pyodermas. Author Peter KLee, Mathew T.       
Zipolli, Arnold N Weinberg, Morton Swartz and Richard A.Johnson Pg. 1876. 
40. Aste N, Pau M. Pityriasis versicolour on groin mimicking erythrasma. Mycoses 
2004; June;  47(5-6): 249-51. 
41. Gupta S. Pityriasis rotunda mimicking tinea cruris/corporis and erythrasma in an 
Indian patient. J. Dermatol 2001 Jan; 28(1): 50-3. 
15 
 
42. Treatment of skin disease. 1st edition. Edited by Mark Lebwohl, Warren R      
Heymann, John Berth Jones, Ian Loulson. Erythrasma by Andrew G. Smith page 
203. 
43. Holdiness MR. Management of cutaneous erythrasma. Drugs 2002; 62(8):       
1131-41. 
44. Wharton JR, Wilson PL, Kincannon JM, Erythrasma treated with single dose        
clarithromycin. Arch Dermatol 1998 Jun; 134(6): 671-2. 
45. Goodman and Gilman’s The pharmacological basis of therapeautics 11th edition:     
edited by Laurence.L.Brunton,John.S.Lazo,Keith.L.Parker.Antifungal agents by 
John.E.Bennet 1230-1238 
46. Drugbank. www.drugbank.ca/drugs/DB0025007.  
47. Generic drugs.  http://www.ndrugs.com/?s=clotrimazole#ixzz3XZJHGUrl  
48. Kucers A.. Fusidate sodium. In: Kucers A, Crowe SM, Grayson ML, Hoy JF, 
editors. The use  of antibiotics. 5th ed. Oxford: Butterworth-Heinemann; 1997. 
p. 580-6. 
49. Hansson S, Singh R, Gudkov AT, Liljas A, Logan DT. Structural insights into 
fusidic  acid resistance and sensitivity in EF-G. J Mol Biol 2005;348:939-49. 
50. Tanaka N, Kinoshita T, Masukawa H. Mechanism of protein synthesis inhibition 
by  fusidic acid and related antibiotics. Biochem Biophys Res Commun 1968; 
30:278-83. 
51. Bodley JW, Zieve FJ, Lin L, Zieve S. Formation of the ribosome-G factor-GDP 
complex in the presence of fusidic acid. Biochem Biophys Res Commun 1969; 
37:437-43. 
52. Collignon P, Turnidge J. Fusidic acid in vitro activity. Int J Antimicrob Agents. 
1999;12 Suppl 2:S45-58 
16 
 
53. Vickers CF. Percutaneous absorption of sodium fusidate and fusidic acid. Br J 
Dermatol. 1969; 81:902-908 
54. Turnidge J. Fusidic acid pharmacology, pharmacokinetics and 
pharmacodynamics. Int J Antimicrob Agents. 1999;12 Suppl 2:S23-34. 
55. Christiansen K. Fusidic acid adverse drug reactions. Int J Antimicrob Agents. 
56. Reimann G, Barthel B, Rockstroh JK, Spatz D, Brockmeyer NH. Effect of 
fusidic acid  on the hepatic cytochrome P450 enzyme system. Int J Clin 
Pharmacol Ther. 1999;37:562-566.  
57. Haman K, Thorn P. Systemic or local treatment of erythrasma?A comparison 
between erythromycin tablets and fucidin cream in general practice. Scand J 
Prim Health Care. 1991;9:35–39. 
58. MacMillan AL, Sarkany I. Specific topical therapy for erythrasma.Br J 
Dermatol. 1970;82:507–509. 
59. Darras-Vercambre S, Carpentier O, Vincent P, Bonnevalle A, Thomas P.        
Photodynamic action of red light for treatment of erythrasma: preliminary        
results. Photodermatol Photoimmunol Photomed. 2006 Jun. 22(3):153-6 
60. Turk BG, Turkmen M, Aytimur D. Antibiotic susceptibility of Corynebacterium 
minutissimum isolated from lesions of Turkish patients with erythrasma.  J Am    
Acad Dermatol. 2011 Dec. 65(6):1230-1.. 
61. Avci O, Tanyildizi T, Kusku E. A comparison between the effectiveness of     
erythromycin, single-dose clarithromycin and topical fusidic acid in the 
treatment of erythrasma. J Dermatolog Treat. 2011 Sep 18. 
62. Seville RH, SomervilleA.  Treatment of erythrasma in a hospital for  mentally      
subnormal . Br J Dermatol 1970;82:502-6. 
17 
 
63. K Hamann, P Thorn .Systemic or Local Treatment of Erythrasma? A 
comparison between Erythromycin  Tablets and Fucidin R Cream in General 
Practice. - Scandinavian journal of primary health care, 1991 - Taylor & Francis 
64. Clayton YM, Knight AG.A clinical double-blind trial of topical miconazole and 
clotrimazole against superficial  fungal infections and erythrasma.. Clin Exp 
Dermatol. 1976 Sep;1(3):225-32. 
65.  Yvonne m. Clayton and Bruce Connor. Comparison of clotrimazole cream, 
Whitfield’s’s's ointment and Nystatin ointment for the topical treatment of 
ringworm infections, pityriasis versicolour, erythrasma and candidiasis.      
British Journal of Dermatology Volume 89, Issue 3, pages 297–303, September      
1973. 
  
18 
 
ERYTHRASMA - A CLINICAL STUDY AND A COMPARTIVE 
STUDY OF TOPICAL 2% FUSIDIC ACID CREAM VS 2% 
CLOTRIMAZOLE CREAM IN THE TREATMENT  OF 
ERYTHRASMA. 
 
Name:                                                               Address: 
Age:                                                                  Marital Status: 
Sex :                                                                  Occupation : 
Case No:                                                            Hospital No: 
HISTORY 
Dark discolouration of flexures:  Yes                          No 
Duration :                                   Yes                           No 
Itching:                                       Yes                           No 
Past History 
Similar illness:                          Yes                         No 
DM              HT               TB          RA                    Others 
Family History 
Similar illness        Partner          Parents                 Children       Others 
Drug History 
Steroids:                                Yes                                 No 
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Menstrual History 
Menarche: 
Periods: 
Menopause: 
EXAMINATION 
General Examination 
Built:                 Well                   Moderate                  Poor 
Height: (m) 
Weight: (kg) 
BMI: 
Anaemia:                     Yes                            No 
Lymphadenopathy:      Yes                           No 
Systemic Examination 
CVS                                RS                          ABDOMEN                                       
CNS 
Dermatological Examination 
Distribution of lesion:            Genitocrural            Axilla                Inframammary            
Others: 
Colour of lesion:                     Reddish brown                 Brown           Black               
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Extent of lesion: 
Nail :       Normal                   Subungual hyperkeratosis                     Onycholysis 
Mucosa:   Normal 
Associated Skin Disorders 
Other Corynebacterium causing disorders:  Trichomycosis axillaries      
                                                                       pitted keratolysis 
Others 
INVESTIGATIONS 
Blood:             Hb                                      Urine:    Albumin      Sugar          Deposits 
Blood sugar: GTT 
Serum cholesterol: 
Optional 
Thyroid function tests: 
ELISA: 
Specific 
Wood’s lamp Examination: 
Gram's stain smear: 
Culture: 
Biopsy: 
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TREATMENT    
2% clotrimazole cream / 2%fusidic acid cream                       
FOLLOW UP 
Day Colour intensity Demarcation 
Wood’s light 
reflection score 
Scaling 
1     
7     
14     
 
PHYSICIAN’S GLOBAL ASSESMENT RESPONSE 
Worsened nil mild moderate marked 
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KEY TO MASTER CHART 
Symptoms 
D - Discolouration 
I – Itching 
B -both 
Sites 
G - Groin 
A - Axilla 
I - Inframammary 
Lesion 
RB- reddish brown 
BR - brown 
BL -black 
Skin Infections 
K - Pitted keratolysis 
T - Trichomycosis 
Associated Systemic Disorders 
O - Obesity 
DM - Diabetes mellitus 
H – Hypothyroidism 
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Other skin lesions 
AN – acanthosis nigricans 
AC - achrochordon 
Treatment  
C –colour intensity 
D -demarcation 
W –wood’s light reflection score 
Assessment  
R- Physician’s global assessment response 
 
  
1 
 
MASTER CHART – GROUP A -2 % CLOTRIMAZOLE CREAM 
Sl 
no 
age sex dur symptoms morphology site otherinfcs 
Other 
skin 
diseases 
systemic 
C 
Red% 
day 
I 
Red% 
day 
DC 
Red% 
day 
S 
Red% 
day 
W 
Red% 
day 
R 
   mon I D B BR RB BL G A IM T K AN AC DM H O 7 14 7 14 7 14 7 14 7 14  
1 28 m 3 + - - - + - + - - - - - - + + + 44 86 42 83 54 88 42 82 64 100 4 
2 32 f 4 - - + - + - + + + - - - - + + - 45 84 43 84 48 84 40 81 68 100 4 
3 35 f 7 - + - - - + + - - - - - + + - + 32 66 33 71 35 74 33 72 45 84 2 
4 35 f 6 - - + - + - + + - - - - - + - - 38 73 37 76 40 79 37 77 57 92 3 
5 36 f 9 - + - - + - + + - - + - + + - + 45 83 46 88 50 84 43 84 65 99 4 
6 34 m 8 - - + - + - - + + - - - - + - + 37 73 36 75 38 78 36 74 56 93 3 
7 31 m 5 - - + - + - + + - - - - - - - - 38 74 39 78 43 84 37 77 54 94 3 
8 35 m 7 + - - - + - + + - - - + + - - - 36 72 36 79 40 80 35 76 55 92 3 
9 39 m 10 - - + - + - + + - - - + + + - + 45 88 46 89 52 87 44 84 64 100 4 
10 42 f 9 - - + - + - + + - - - + + + - - 44 86 43 87 46 85 43 85 63 100 4 
11 41 f 7 - + - - - + + + - - - - - + - - 46 89 47 90 44 87 45 86 64 100 4 
12 42 f 7 - + - - + - + - - - - + - - - + 35 74 32 75 36 74 34 73 63 99 3 
13 45 f 9 - + - - + - + + - - - + + + - + 45 86 46 92 47 89 46 84 67 100 4 
14 44 f 10 - + - -- + - + + - - + - - - - + 31 72 28 70 32 74 32 72 44 80 2 
15 41 m 11 - - + - + - + + - - - - + + - - 47 89 48 83 47 87 45 86 64 99 4 
16 46 m 14 - + - - + - + + - + - - - + + + 46 86 46 89 45 86 44 87 63 100 4 
17 47 m 15 - - + - + - + + - - - - + - - + 35 77 34 75 36 75 34 74 54 86 3 
18 48 f 10 - + - - + - + + - - - - - - - - 44 85 46 84 45 90 43 86 62 100 4 
19 49 f 16 + - - - + - + + - - - - + - - + 46 88 43 85 44 86 45 83 65 98 4 
20 42 f 17 - - + - + - + - + - - - - - - - 36 74 37 73 37 76 35 85 53 86 3 
21 52 m 19 + - - - + - + + - - + - - + + + 46 86 45 92 45 86 45 84 67 99 4 
22 50 m 18 - + - - + - + + - - - - - + + + 36 74 34 75 35 75 35 73 53 89 3 
23 51 f 10 + - - - + - + + - - - - - + + + 46 88 47 90 47 84 45 87 65 100 4 
24 55 m 11 - + - - + - + - - - - - - + - - 45 89 44 86 43 83 44 85 66 98 4 
25 56 m 12 + - - - + - + + - - - - - - - + 44 85 44 88 45 88 43 86 67 100 4 
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                                   MASTER CHART – GROUP B -2 % FUSIDIC ACID CREAM  
Sl 
no 
age sex dur symptoms morphology site other infns 
Other 
skin ds 
Other syst 
diseases 
C 
red% 
day 
I 
red % 
day 
DC 
Red% 
day 
S 
Red% 
day 
W 
Red% 
day 
R 
    I D B BR RB BL A G IM T K AC AN DM H O 7 14 7 14 7 14 7 14 7 14  
1 26 f 6 - + - - + - + + - - - - - - - + 53 82 43 84 56 87 40 75 58 80 3 
2 36 f 3 + - - - + - + - - - - - + + - + 57 92 55 98 62 90 56 81 66 100 4 
3 38 m 6 - - - - + - + + - - - - - + + + 51 94 52 93 57 93 52 82 75 100 4 
4 40 m 2 - + - - + - + - - - - - + - - - 50 90 56 95 55 93 54 79 68 100 4 
5 40 f 7 - + - - - + + - - - - + - + - + 46 92 48 88 58 82 55 60 66 90 3 
6 41 f 8 - - + - + - - + - - - - - - + - 57 89 51 92 53 95 52 75 70 99 4 
7 42 m 3 + - - - + - + - - - - - - + - + 56 88 53 94 51 94 53 73 58 98 4 
8 43 f 16 - - + + - - - + - - - - - + - + 53 94 52 93 55 96 55 75 65 100 4 
9 44 f 9 - + - - + - + + - - - - - + - - 49 96 51 90 46 77 48 70 53 86 3 
10 45 m 5 - - + - + - - + - - - + + + - + 57 92 53 89 57 96 49 73 69 100 4 
11 43 f 14 + - - - + - + + - - - - - + - + 59 98 54 92 53 99 53 71 73 100 4 
12 46 f 8 - - + - + - + + + - - - - - - - 52 96 50 90 55 98 55 72 75 100 4 
13 47 f 7 - - + + + - + + - - - - - + + - 51 97 49 88 58 95 52 76 64 100 4 
14 41 m 4 - + - - + - + + - + - - - - - + 50 95 51 94 48 86 45 65 51 84 3 
15 42 f 9 - - + - + - + + - - - - - + - - 52 92 49 96 55 94 53 73 75 100 4 
16 43 m 10 + - - - + - + + - - - + + - + + 51 88 53 95 46 96 55 62 52 88 3 
17 49 f 11 - - + - + - + + - - - - - + - - 57 94 56 97 59 95 51 71 69 100 4 
18 44 f 12 - + - - + - + + - - - - - - - + 55 90 52 92 55 99 52 77 74 100 4 
19 53 m 9 - - + - + - + + - - - - + + - + 54 95 51 93 55 95 54 76 64 99 4 
20 51 f 9 - - + - + - + + - - + - - - - + 59 88 55 90 58 94 52 75 73 100 4 
21 55 f 11 - + - - + - + + - - - - + + - - 62 83 57 89 54 98 49 74 72 100 4 
22 56 m 7 - - + + - - + + - - - - - - - + 51 89 49 93 58 97 51 77 68 100 4 
23 57 f 6 - + - - + - + + - - + - - + - - 55 88 48 95 56 99 52 74 74 100 4 
24 52 m 18 - - + - + - + + - - - - - - - + 58 90 53 99 57 96 55 78 75 100 4 
25 58 m 20 - - + - + - + + - - - - - - - - 63 92 55 92 61 99 53 77 76 100 4 
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